1,354
Registered trials
352
Recruiting
948
Completed trials
415
Sponsors active
1,433
Research sites
Phase III:
685
Phase II/III:
49
Phase II:
318
Phase I/II:
63
Phase III/IV:
15
Phase IV:
37
Phase I:
64
Phase I (Other):
84
Phase I (FiH):
36
Other:
8
Oversight events in trials active here:
74 serious breaches
405 temporary halts
29 urgent safety measures
51 unexpected events
78 corrective measures
across 247 trials
View oversight register →
Top conditions
Non-small cell lung cancer
42
Non-small cell lung cancer metastatic
13
Systemic lupus erythematosus
12
Crohn's disease
12
Colitis ulcerative
12
Squamous cell carcinoma of head and neck
11
Dermatitis atopic
11
Pulmonary arterial hypertension
10
Hormone receptor positive HER2 negative breast cancer
10
Breast cancer
9
Obesity
9
Diffuse large B-cell lymphoma
9
Top sponsors
Merck Sharp & Dohme LLC
91
F. Hoffmann-La Roche AG
78
Janssen - Cilag International
73
AstraZeneca AB
70
AbbVie Deutschland GmbH & Co. KG
63
Novartis Pharma AG
42
Boehringer Ingelheim International GmbH
37
Novo Nordisk A/S
31
Amgen Inc.
29
Bayer AG
28
Bristol-Myers Squibb Services Unlimited Company
25
Eli Lilly & Co.
24
Cities with most trials
All 409 cities →All trials — page 157
1,354 totalShowing 3,745–1,354 of 1,354 trials